Every one of those 1 sits in a single category, pharma. Indonesia is most often covered alongside Australia, which appears in 1 of these 1 story. Indonesia appears in 1 tracked Biotech story from June 15, 2026. The tracked stories average 4 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Indonesia
Every one of those 1 sits in a single category, pharma. Indonesia is most often covered alongside Australia, which appears in 1 of these 1 story. Indonesia appears in 1 tracked Biotech story from June 15, 2026. The tracked stories average 4 original sources each.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Indonesia. Shared-story counts are live from our verified record — not editorial picks.
Biotech and pharma sectors face supply chain risks from the West Asia situation, but the Indian government claims a multi-pronged strategy will prevent shortages. While concrete fertilizer diversification details are given, pharma-specific mitigation remains less specific, though close monitoring is emphasized.